High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision.
暂无分享,去创建一个
R. Barzilay | C. Lehman | L. Yu | M. Bahl | N. Locascio | Adam B Yedidia
[1] Ross W. Filice,et al. Implementing Machine Learning in Radiology Practice and Research. , 2017, AJR. American journal of roentgenology.
[2] Hongmin Cai,et al. Discrimination of Breast Cancer with Microcalcifications on Mammography by Deep Learning , 2016, Scientific Reports.
[3] Amy Cantor,et al. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation , 2016, Annals of Internal Medicine.
[4] Song Liu,et al. Lobular neoplasia detected in MRI-guided core biopsy carries a high risk for upgrade: a study of 63 cases from four different institutions , 2016, Modern Pathology.
[5] Gillian D Sanders,et al. Benefits and Harms of Breast Cancer Screening: A Systematic Review. , 2015, JAMA.
[6] Karla Kerlikowske,et al. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: A report from the Breast Cancer Surveillance Consortium , 2015, Cancer.
[7] A. Nassar,et al. Radial scar/complex sclerosing lesions: a clinicopathologic correlation study from a single institution. , 2015, Annals of diagnostic pathology.
[8] R. Simmons,et al. Advocating Nonsurgical Management of Patients With Small, Incidental Radial Scars at the Time of Needle Core Biopsy: A Study of 77 Cases. , 2015, Archives of pathology & laboratory medicine.
[9] Colleen H. Neal,et al. Is the upgrade rate of atypical ductal hyperplasia diagnosed by core needle biopsy of calcifications different for digital and film-screen mammography? , 2014, AJR. American journal of roentgenology.
[10] D. Miglioretti,et al. Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium. , 2014, American journal of surgery.
[11] T. D’alfonso,et al. Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target. , 2013, Archives of pathology & laboratory medicine.
[12] A. Soran,et al. Rationale of Excisional Biopsy After the Diagnosis of Benign Radial Scar on Core Biopsy: A Single Institutional Outcome Analysis , 2013, American journal of clinical oncology.
[13] G. McGinty,et al. Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy , 2013, Modern Pathology.
[14] Carol Reynolds,et al. Management of Benign Intraductal Solitary Papilloma Diagnosed on Core Needle Biopsy , 2013, Annals of Surgical Oncology.
[15] H. Kuerer,et al. Multidisciplinary considerations in the management of high-risk breast lesions. , 2012, AJR. American journal of roentgenology.
[16] A. Arieno,et al. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. , 2012, AJR. American journal of roentgenology.
[17] D. Georgian-Smith,et al. Variations in physician recommendations for surgery after diagnosis of a high-risk lesion on breast core needle biopsy. , 2012, AJR. American journal of roentgenology.
[18] F. Bellafiore,et al. Flat epithelial atypia with and without atypical ductal hyperplasia: to re-excise or not. Results of a 5-year prospective study , 2012, Virchows Archiv.
[19] E. Deperi,et al. Long-Term Follow-up of Lobular Neoplasia (Atypical Lobular Hyperplasia/Lobular Carcinoma In Situ) Diagnosed on Core Needle Biopsy , 2012, Annals of Surgical Oncology.
[20] S. Gabram,et al. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. , 2012, Journal of the American College of Surgeons.
[21] R. Rouzier,et al. Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: an external validation study. , 2012, European journal of cancer.
[22] V. Bécette,et al. Rates of upgrade to malignancy for 271 cases of flat epithelial atypia (FEA) diagnosed by breast core biopsy , 2012, Breast Cancer Research and Treatment.
[23] S. Meterissian,et al. Flat epithelial atypia of the breast: pathological-radiological correlation. , 2011, AJR. American journal of roentgenology.
[24] N. Sneige,et al. Atypical Ductal Hyperplasia in Directional Vacuum-Assisted Biopsy of Breast Microcalcifications: Considerations for Surgical Excision , 2011, Annals of Surgical Oncology.
[25] D. Georgian-Smith,et al. Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective. , 2010, Radiologic clinics of North America.
[26] D. Georgian-Smith,et al. Excision of high-risk breast lesions on needle biopsy: is there a standard of core? , 2009, AJR. American journal of roentgenology.
[27] Stephen R. Marsland,et al. Machine Learning - An Algorithmic Perspective , 2009, Chapman and Hall / CRC machine learning and pattern recognition series.
[28] C. Lehman,et al. Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge. , 2009, AJR. American journal of roentgenology.
[29] I. Treilleux,et al. Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. , 2008, American journal of surgery.
[30] G. Gong,et al. Papillary lesions of the breast diagnosed at percutaneous sonographically guided biopsy: comparison of sonographic features and biopsy methods. , 2008, AJR. American journal of roentgenology.
[31] Rachel F Brem,et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. , 2008, AJR. American journal of roentgenology.
[32] S. Wall,et al. Breast cancer screening with mammography: overview of Swedish randomised trials , 1993, The Lancet.
[33] Thomas M. Cover,et al. Elements of Information Theory , 2005 .
[34] L. Tabár,et al. REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.